Literature DB >> 9371532

Severe thrombocytopenia suggesting immunological mechanisms in two cases of vivax malaria.

S Yamaguchi1, T Kubota, T Yamagishi, K Okamoto, T Izumi, M Takada, S Kanou, M Suzuki, J Tsuchiya, T Naruse.   

Abstract

Case 1: A 27-year-old woman, referred to our hospital because of relapsing fever after travel to Thailand, was given a diagnosis of vivax malaria. Clinical investigation revealed thrombocytopenia, elevated platelet-associated IgG (PAIgG), and negative antibody against Plasmodium vivax antigen. After antimalarial treatment, the levels of both the platelets and PAIgG returned to normal. Case 2: A 28-year-old Sri Lankan man was admitted to our hospital with a complaint of fever. The patient had thrombocytopenia, elevated PAIgG, and positive antibody against Plasmodium vivax antigen. He contracted malaria in Sri Lanka about 6 months prior to this admission. After treatment, the platelet count and PAIgG level returned to normal. In these two cases, high levels of PAIgG may have been involved in the development of the thrombocytopenia. In the first patient, in particular, the thrombocytopenia was thought to be induced by some immunological mechanism prior to the detection of antimaralial antibodies in serum.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9371532     DOI: 10.1002/(sici)1096-8652(199711)56:3<183::aid-ajh9>3.0.co;2-u

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  19 in total

1.  The unusual presentation of a usual organism - the changing spectrum of the clinical manifestations of Plasmodium vivax malaria in children: a retrospective study.

Authors:  Shobha Sharma; Kailash Chandra Aggarwal; Shivani Deswal; Deepak Raut; Neelam Roy; Rohit Kapoor
Journal:  J Clin Diagn Res       Date:  2013-09-10

2.  Benign tertian malaria: how benign is it today?

Authors:  Dinesh Yadav; Jagdish Chandra; Ashok Kumar Dutta
Journal:  Indian J Pediatr       Date:  2011-06-25       Impact factor: 1.967

3.  Changing profile of severe malaria in north Indian children.

Authors:  Dinesh Yadav; Jagdish Chandra; Satinder Aneja; Virendra Kumar; Praveen Kumar; Ashok Kumar Dutta
Journal:  Indian J Pediatr       Date:  2011-11-18       Impact factor: 1.967

4.  A comparative study of clinical profiles of vivax and falciparum malaria in children at a tertiary care centre in uttarakhand.

Authors:  Ragini Singh; Shruti Kumar; S K Rana; Brijesh Thakur; S P Singh
Journal:  J Clin Diagn Res       Date:  2013-09-18

Review 5.  The role of platelets in the pathogenesis of cerebral malaria.

Authors:  Dermot Cox; Sam McConkey
Journal:  Cell Mol Life Sci       Date:  2009-11-29       Impact factor: 9.261

6.  The clinicopathologic manifestations of Plasmodium vivax malaria in children: a growing menace.

Authors:  Prasun Bhattacharjee; Suparna Dubey; Vijay Kumar Gupta; Prerana Agarwal; Mathura Prasad Mahato
Journal:  J Clin Diagn Res       Date:  2013-03-25

7.  Does activation of the blood coagulation cascade have a role in malaria pathogenesis?

Authors:  Ivo M B Francischetti
Journal:  Trends Parasitol       Date:  2008-05-06

Review 8.  Blood coagulation, inflammation, and malaria.

Authors:  Ivo M B Francischetti; Karl B Seydel; Robson Q Monteiro
Journal:  Microcirculation       Date:  2008-02       Impact factor: 2.628

9.  Thrombocytopenia in Plasmodium vivax malaria is related to platelets phagocytosis.

Authors:  Helena Cristina C Coelho; Stefanie C P Lopes; João Paulo D Pimentel; Paulo A Nogueira; Fábio T M Costa; André M Siqueira; Gisely C Melo; Wuelton M Monteiro; Adriana Malheiro; Marcus V G Lacerda
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

10.  Changes in the total leukocyte and platelet counts in Papuan and non Papuan adults from northeast Papua infected with acute Plasmodium vivax or uncomplicated Plasmodium falciparum malaria.

Authors:  Walter R J Taylor; Hendra Widjaja; Hasan Basri; Colin Ohrt; Taufik Taufik; Emiliana Tjitra; Samuel Baso; David Fryauff; Stephen L Hoffman; Thomas L Richie
Journal:  Malar J       Date:  2008-12-18       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.